Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals

Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals

Abstract Psychedelic-assisted therapy (PAT) with substances like psilocybin and MDMA has shown promise for conditions including depression and post-traumatic stress disorder. Psilocybin and MDMA may become approved medicines in the coming decade. This study assessed knowledge and attitudes regarding...

Full description

Bibliographic Details
Main Authors: Erin Wang, David S. Mathai, Natalie Gukasyan, Sandeep Nayak, Albert Garcia-Romeu
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Psychedelic
Psilocybin
MDMA
Hallucinogen
Attitudes
Online Access:https://doi.org/10.1038/s41598-024-78736-1

Internet

https://doi.org/10.1038/s41598-024-78736-1

Similar Items